XML 112 R51.htm IDEA: XBRL DOCUMENT
v3.22.4

Unit-based Compensation (Q3) (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2022 | Dec. 31, 2021
Unit and Stock-based Compensation [Abstract] |  |
Key Input Assumptions Used in the Black-Scholes Option-Pricing Model | The following table summarizes the key input assumptions used in the Black-Scholes option-pricing model to estimate the fair value of unit options granted for the nine months ended September 30, 2022 and 2021:
| ​ | ​ | Nine Months Ended September 30,
| ​ | ​ | 2022 | ​ | ​ | 2021
Expected life of units (in years)(1) | ​ | ​ | 4.57 - 4.61 | ​ | ​ | 4.55 - 4.61
Expected unit price volatility(2) | ​ | ​ | 56.39% - 60.87% | ​ | ​ | 48.20% - 56.46%
Risk free interest rate(3) | ​ | ​ | 1.37% - 3.05% | ​ | ​ | 0.32% - 0.78%
Expected dividend yield(4) | ​ | ​ | —% | ​ | ​ | —%
Weighted average grant-date fair value per unit of unit options granted | ​ | ​ | $2.75 - $5.81 | ​ | ​ | $1.80 - $2.17
Fair value per common unit | ​ | ​ | $5.89 - $11.13 | ​ | ​ | $4.50 - $4.98
(1) | The expected term for award is determined using the simplified method, which estimates the expected term using the contractual life of the option and the vesting period.
(2) | Expected volatility is based on historical volatilities of a publicly traded per group over a period equivalent to the expected term of the awards.
(3) | The risk-free interest rate is based on the U.S. Treasury yield of treasury bonds with a maturity that approximates the expected term of the awards.
(4) | Prior to June 10, 2022, the Company has not historically paid cash dividends on its common units. On June 10, 2022, the Company’s Board of Managers approved a special distribution as described in Note 9, and does not expect to pay any normal course cash dividends on its common units in the foreseeable future.
Unit Option Activity | The following table summarizes the unit option activity for the nine months ended September 30, 2022:
| ​ | ​ | Number of Options | ​ | ​ | Weighted Average Exercise Price
Outstanding at December 31, 2021 | ​ | ​ | 3,442,397 | ​ | ​ | $4.97
Granted | ​ | ​ | 867,050 | ​ | ​ | $10.37
Exercised | ​ | ​ | (240,205) | ​ | ​ | $4.73
Forfeited | ​ | ​ | (886,519) | ​ | ​ | $4.63
Outstanding at September 30, 2022 | ​ | ​ | 3,182,723 | ​ | ​ | $6.56
| The following table summarizes the unit option activity for the periods ended December 31, 2021 and December 31, 2020:
| ​ | ​ | Number of Options | ​ | ​ | Weighted Average Exercise Price | ​ | ​ | Weighted Average Remaining Contractual Life (Years) | ​ | ​ | Aggregate Intrinsic Value (in thousands)
Outstanding at June 11, 2020 | ​ | ​ | — | ​ | ​ | $— | ​ | ​ |  | ​ | ​ |
Granted | ​ | ​ | 2,708,025 | ​ | ​ | $4.50 | ​ | ​ |  | ​ | ​ |
Forfeited | ​ | ​ | (183,820) | ​ | ​ | $4.50 | ​ | ​ |  | ​ | ​ |
Outstanding at December 31, 2020 | ​ | ​ | 2,524,205 | ​ | ​ | $4.50 | ​ | ​ | 6.6 | ​ | ​ | $680
Granted | ​ | ​ | 1,416,800 | ​ | ​ | $5.66 | ​ | ​ |  | ​ | ​ |
Exercised | ​ | ​ | (300,065) | ​ | ​ | $4.50 | ​ | ​ |  | ​ | ​ |
Forfeited | ​ | ​ | (198,543) | ​ | ​ | $4.58 | ​ | ​ |  | ​ | ​ |
Outstanding at December 31, 2021 | ​ | ​ | 3,442,397 | ​ | ​ | $4.97 | ​ | ​ | 6.1 | ​ | ​ | $3,159
| ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |
Exercisable at December 31, 2020 | ​ | ​ | — | ​ | ​ | $— | ​ | ​ | — | ​ | ​ | $—
Exercisable at December 31, 2021 | ​ | ​ | 510,686 | ​ | ​ | $4.52 | ​ | ​ | 5.7 | ​ | ​ | $699
Series P Units Activity | A summary of Series P Units activity for the nine months ended September 30, 2022 is presented below:
| ​ | ​ | Number of Units | ​ | ​ | Weighted Average Fair Value(1)
Unvested at December 31, 2021 | ​ | ​ | 4,306,636 | ​ | ​ | $2.07
Vested | ​ | ​ | (3,293,464) | ​ | ​ | $5.36
Unvested at September 30, 2022 | ​ | ​ | 1,013,172 | ​ | ​ | $7.32
(1) | The weighted average fair value for unvested Series P units at December 31, 2021 is based on the grant date fair value. The weighted average fair value of the vested Series P units in 2022 and the unvested Series P units at September 30, 2022 considered the remeasured fair value of Series P upon modification (discussed below).
| A summary of Series P Units activity for the Successor for the year ended December 31, 2021 is presented below:
| ​ | ​ | Number of Units | ​ | ​ | Weighted Average Grant Date Fair Value
Unvested at June 11, 2020 | ​ | ​ | — | ​ | ​ | $—
Granted | ​ | ​ | 4,052,684 | ​ | ​ | $2.00
Vested | ​ | ​ | (159,112) | ​ | ​ | $2.00
Unvested at December 31, 2020 | ​ | ​ | 3,893,572 | ​ | ​ | $2.00
Granted | ​ | ​ | 1,013,171 | ​ | ​ | $2.42
Vested | ​ | ​ | (600,107) | ​ | ​ | $2.22
Unvested at December 31, 2021 | ​ | ​ | 4,306,636 | ​ | ​ | $2.07
Summary of Unit-Based Compensation Expenses | The following table summarizes unit-based compensation expenses for the three and nine months ended September 30, 2022 and 2021, respectively:
| ​ | ​ | Three Months Ended September 30, | ​ | ​ | Nine Months Ended September 30,
| ​ | ​ | 2022 | ​ | ​ | 2021 | ​ | ​ | 2022 | ​ | ​ | 2021
Selling, general and administrative expenses | ​ | ​ | $9,435 | ​ | ​ | $593 | ​ | ​ | $22,870 | ​ | ​ | $1,623
Product development expenses | ​ | ​ | 251 | ​ | ​ | 71 | ​ | ​ | 483 | ​ | ​ | 183
| ​ | ​ | $9,686 | ​ | ​ | $664 | ​ | ​ | $23,353 | ​ | ​ | $1,806
| The following table summarizes unit-based compensation expenses for the year ended December 31, 2021 and for the period from June 11, 2020 through December 31, 2020, for the Successor, and stock-based compensation expenses for the period from January 1, 2020 through June 10, 2020 and for the year ended December 31, 2019, for the Predecessor:
| ​ | ​ | Successor | ​ | ​ | Predecessor
| ​ | ​ | Year ended December 31, 2021 | ​ | ​ | From June 11, 2020 through December 31, 2020 | ​ | ​ | From January 1, 2020 through June 10, 2020 | ​ | ​ | Year ended December 31, 2019
Selling, general and administrative expenses | ​ | ​ | $2,217 | ​ | ​ | $846 | ​ | ​ | $280 | ​ | ​ | $4,636
Product development expenses | ​ | ​ | 268 | ​ | ​ | 70 | ​ | ​ | 63 | ​ | ​ | 2,144
| ​ | ​ | $2,485 | ​ | ​ | $916 | ​ | ​ | $343 | ​ | ​ | $6,780

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration